RBF Capital’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-58,753
Closed -$44.6K 600
2024
Q3
$44.6K Hold
58,753
﹤0.01% 591
2024
Q2
$106K Sell
58,753
-1,432
-2% -$4.13K 0.01% 549
2024
Q1
$286K Sell
60,185
-1,500
-2% -$5.27K 0.02% 472
2023
Q4
$179K Sell
61,685
-2,100
-3% -$3.31K 0.01% 507
2023
Q3
$86.1K Sell
63,785
-6,215
-9% -$10.9K 0.01% 513
2023
Q2
$151K Hold
70,000
0.01% 481
2023
Q1
$204K Hold
70,000
0.01% 449
2022
Q4
$481K Sell
70,000
-23,999
-26% -$113K 0.04% 340
2022
Q3
$299K Sell
93,999
-48,786
-34% -$177K 0.03% 410
2022
Q2
$433K Hold
142,785
0.03% 362
2022
Q1
$433K Buy
142,785
+17,785
+14% +$60.1K 0.03% 374
2021
Q4
$558K Buy
+125,000
New +$612K 0.03% 351

Other funds holding STIM

RBF Capital's STIM Position: Q4 2024 in Review

RBF Capital sold out of Neuronetics (STIM) in Q4 2024, closing a stake of 58,753 shares — an estimated $44.6K sold.

RBF Capital first reported a position in STIM in Q4 2021 and held it in 12 quarters. The position peaked at $558K in Q4 2021. 45 funds tracked by Wall St. Rank hold STIM as of Q4 2024.

  • RBF Capital reported no remaining Neuronetics position as of Q4 2024 after selling out during the quarter.
  • RBF Capital sold 58,753 Neuronetics shares in Q4 2024, an estimated $44.6K.
  • RBF Capital first reported a position in Neuronetics in Q4 2021 and held it in 12 quarters.
  • RBF Capital's Neuronetics position peaked at $558K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Neuronetics as of Q4 2024.

Based on RBF Capital's 13F filing for Q4 2024, filed 14 Feb 2025.